Cargando…
Partial signaling by CD8+ T cells in response to antagonist ligands
Structural variants of an agonist peptide-major histocompatibility complex (MHC) molecule ligand can show partial agonist and/or antagonist properties. A number of such altered ligands appear to act as pure antagonists. They lack any detectable ability to induce T cell effector function and have bee...
Formato: | Texto |
---|---|
Lenguaje: | English |
Publicado: |
The Rockefeller University Press
1996
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2192672/ https://www.ncbi.nlm.nih.gov/pubmed/8691128 |
Ejemplares similares
-
Dissociation of Intracellular Signaling Pathways in Response to Partial Agonist Ligands of the T Cell Receptor
por: Chau, Luan A., et al.
Publicado: (1998) -
Allelic Variation of MHC Structure Alters Peptide Ligands to Induce Atypical Partial Agonistic CD8(+) T Cell Function
por: Lim, Dong-Gyun, et al.
Publicado: (2003) -
A Critical Role for Cd40–Cd40 Ligand Interactions in Amplification of the Mucosal Cd8 T Cell Response
por: Lefrançois, Leo, et al.
Publicado: (1999) -
CD3 Ligation on Immature Thymocytes Generates Antagonist-like Signals Appropriate for CD8 Lineage Commitment, Independently of T Cell Receptor Specificity
por: Albert Basson, M., et al.
Publicado: (1998) -
Tuning antiviral CD8 T-cell response via proline-altered peptide ligand vaccination
por: Duru, Adil Doganay, et al.
Publicado: (2020)